1-4 of 4
Patrick G. Morris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer

Ian Krop, Vandana Abramson, Marco Colleoni, Tiffany Traina, Frankie Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G. Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M. Kelly, Eric Winer, Denise A. Yardley
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (23): 6149–6157.
https://doi.org/10.1158/1078-0432.CCR-20-1693
Published: 01 December 2020
View article titled, A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer
Open the PDF for A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer

Neil M. Iyengar, Xi Kathy Zhou, Ayca Gucalp, Patrick G. Morris, Louise R. Howe, Dilip D. Giri, Monica Morrow, Hanhan Wang, Michael Pollak, Lee W. Jones, Clifford A. Hudis, Andrew J. Dannenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2283–2289.
https://doi.org/10.1158/1078-0432.CCR-15-2239
Published: 01 May 2016
View article titled, Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer
Open the PDF for Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib

Patrick G. Morris, Carol Chen, Richard Steingart, Martin Fleisher, Nancy Lin, Beverly Moy, Steven Come, Steven Sugarman, Alyson Abbruzzi, Robert Lehman, Sujata Patil, Maura Dickler, Heather L. McArthur, Eric Winer, Larry Norton, Clifford A. Hudis, Chau T. Dang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3490–3499.
https://doi.org/10.1158/1078-0432.CCR-10-1359
Published: 15 May 2011
View article titled, Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
Open the PDF for Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib in another window
Journal Articles

Microtubule Active Agents: Beyond the Taxane Frontier

Patrick G. Morris, Monica N. Fornier
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7167–7172.
https://doi.org/10.1158/1078-0432.CCR-08-0169
Published: 14 November 2008
View article titled, Microtubule Active Agents: Beyond the Taxane Frontier
Open the PDF for Microtubule Active Agents: Beyond the Taxane Frontier in another window